Innovation1 Biotech Inc (IVBT)
Innovation1 Biotech Inc. is a healthcare company listed on OTC Markets under the ticker IVBT. The company is focused on researching, developing, producing, and selling pharmaceutical products. Its current product set includes natural supplements marketed for symptoms associated with flu and long COVID, sold under the NutraFlu and Nutravid19 brands, along with other supplement and medical nutrition products. Innovation1 Biotech is also advancing NLC001, which is in Phase II clinical testing for long COVID and other viral indications. The company is based in New York, New York.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-IVBT
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
July 22, 2026
|
—
|
—
|
—
|
4.494 K
|
—
|
—
|
—
|
—
|
—
|
—
|
